Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2004 Mar;112(4):403–412. doi: 10.1289/ehp.6758

Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor.

Charles D Johnson 1, Yoganand Balagurunathan 1, Mahlet G Tadesse 1, M Hadi Falahatpisheh 1, Marcel Brun 1, Mary K Walker 1, Edward R Dougherty 1, Kenneth S Ramos 1
PMCID: PMC1241891  PMID: 15033587

Abstract

The co-expression of genes coupled to additive probabilistic relationships was used to identify gene sets predictive of the complex biological interactions regulated by ligands of the aryl hydrocarbon receptor ((Italic)Ahr(/Italic)). To maximize the number of possible gene-gene combinations, data sets from murine embryonic kidney, fetal heart, and vascular smooth muscle cells challenged (Italic)in vitro(/Italic) with ligands of the (Italic)Ahr(/Italic) were used to create predictor/training data sets. Biologically relevant gene predictor sets were calculated for (Italic)Ahr(/Italic), cytochrome P450 1B1, insulin-like growth factor-binding protein-5, lysyl oxidase, and osteopontin. Transcript levels were categorized into ternary expressions and target genes selected from the data set and tested for all possible combinations using three gene sets as predictors of transitional level. The goodness of prediction for each set was quantified using a multivariate nonlinear coefficient of determination. Evidence is presented that predictor gene combinations can be effectively used to resolve gene-gene interactions regulated by (Italic)Ahr(/Italic) ligands. (Italic)Key words:(/Italic) aryl hydrocarbon receptor, bioinformatics, gene networks, genomics. (Italic)Environ Health Perspect (/Italic)112:403-412 (2004). [Online 14 January 2004]

Full Text

The Full Text of this article is available as a PDF (2.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando J., Tsuboi H., Korenaga R., Takahashi K., Kosaki K., Isshiki M., Tojo T., Takada Y., Kamiya A. Differential display and cloning of shear stress-responsive messenger RNAs in human endothelial cells. Biochem Biophys Res Commun. 1996 Aug 14;225(2):347–351. doi: 10.1006/bbrc.1996.1178. [DOI] [PubMed] [Google Scholar]
  2. Andreola F., Fernandez-Salguero P. M., Chiantore M. V., Petkovich M. P., Gonzalez F. J., De Luca L. M. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 1997 Jul 15;57(14):2835–2838. [PubMed] [Google Scholar]
  3. Bittinger Mark A., Nguyen Linh P., Bradfield Christopher A. Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor. Mol Pharmacol. 2003 Sep;64(3):550–556. doi: 10.1124/mol.64.3.550. [DOI] [PubMed] [Google Scholar]
  4. Buters Jeroen T. M., Mahadevan Brinda, Quintanilla-Martinez Leticia, Gonzalez Frank J., Greim Helmut, Baird William M., Luch Andreas. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. Chem Res Toxicol. 2002 Sep;15(9):1127–1135. doi: 10.1021/tx020017q. [DOI] [PubMed] [Google Scholar]
  5. Carlson David B., Perdew Gary H. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol. 2002;16(6):317–325. doi: 10.1002/jbt.10051. [DOI] [PubMed] [Google Scholar]
  6. Carver L. A., Bradfield C. A. Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem. 1997 Apr 25;272(17):11452–11456. doi: 10.1074/jbc.272.17.11452. [DOI] [PubMed] [Google Scholar]
  7. Chapman R. S., Lourenco P. C., Tonner E., Flint D. J., Selbert S., Takeda K., Akira S., Clarke A. R., Watson C. J. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev. 1999 Oct 1;13(19):2604–2616. doi: 10.1101/gad.13.19.2604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chellaiah M. A., Kizer N., Biswas R., Alvarez U., Strauss-Schoenberger J., Rifas L., Rittling S. R., Denhardt D. T., Hruska K. A. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell. 2003 Jan;14(1):173–189. doi: 10.1091/mbc.E02-06-0354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Coopman P. J., Do M. T., Barth M., Bowden E. T., Hayes A. J., Basyuk E., Blancato J. K., Vezza P. R., McLeskey S. W., Mangeat P. H. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature. 2000 Aug 17;406(6797):742–747. doi: 10.1038/35021086. [DOI] [PubMed] [Google Scholar]
  10. Dailly Y. P., Zhou Y., Linkhart T. A., Baylink D. J., Strong D. D. Structure and characterization of the human insulin-like growth factor binding protein (IGFBP)-6 promoter: identification of a functional retinoid response element. Biochim Biophys Acta. 2001 Mar 19;1518(1-2):145–151. doi: 10.1016/s0167-4781(01)00192-0. [DOI] [PubMed] [Google Scholar]
  11. Denhardt D. T., Giachelli C. M., Rittling S. R. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol. 2001;41:723–749. doi: 10.1146/annurev.pharmtox.41.1.723. [DOI] [PubMed] [Google Scholar]
  12. Denison Michael S., Nagy Scott R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol. 2002 Jan 10;43:309–334. doi: 10.1146/annurev.pharmtox.43.100901.135828. [DOI] [PubMed] [Google Scholar]
  13. Duan C., Hawes S. B., Prevette T., Clemmons D. R. Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem. 1996 Feb 23;271(8):4280–4288. doi: 10.1074/jbc.271.8.4280. [DOI] [PubMed] [Google Scholar]
  14. Falahatpisheh M. Hadi, Ramos Kenneth S. Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing. Oncogene. 2003 Apr 10;22(14):2160–2171. doi: 10.1038/sj.onc.1206238. [DOI] [PubMed] [Google Scholar]
  15. Gonzalez F. J., Fernandez-Salguero P. The aryl hydrocarbon receptor: studies using the AHR-null mice. Drug Metab Dispos. 1998 Dec;26(12):1194–1198. [PubMed] [Google Scholar]
  16. Horie M., Okutomi K., Taniguchi Y., Ohbuchi Y., Suzuki M., Takahashi E. Isolation and characterization of a new member of the human Ly6 gene family (LY6H). Genomics. 1998 Nov 1;53(3):365–368. doi: 10.1006/geno.1998.5462. [DOI] [PubMed] [Google Scholar]
  17. Huang Erich, Ishida Seiichi, Pittman Jennifer, Dressman Holly, Bild Andrea, Kloos Mark, D'Amico Mark, Pestell Richard G., West Mike, Nevins Joseph R. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet. 2003 Jun;34(2):226–230. doi: 10.1038/ng1167. [DOI] [PubMed] [Google Scholar]
  18. Johnston M. C., Bronsky P. T. Prenatal craniofacial development: new insights on normal and abnormal mechanisms. Crit Rev Oral Biol Med. 1995;6(4):368–422. doi: 10.1177/10454411950060040601. [DOI] [PubMed] [Google Scholar]
  19. Kerkvliet Nancy I., Shepherd David M., Baecher-Steppan Linda. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol Appl Pharmacol. 2002 Dec 1;185(2):146–152. doi: 10.1006/taap.2002.9537. [DOI] [PubMed] [Google Scholar]
  20. Kerzee J. K., Ramos K. S. Activation of c-Ha-ras by benzo(a)pyrene in vascular smooth muscle cells involves redox stress and aryl hydrocarbon receptor. Mol Pharmacol. 2000 Jul;58(1):152–158. doi: 10.1124/mol.58.1.152. [DOI] [PubMed] [Google Scholar]
  21. Khalsa P. S., Zhang C., Sommerfeldt D., Hadjiargyrou M. Expression of integrin alpha2beta1 in axons and receptive endings of neurons in rat, hairy skin. Neurosci Lett. 2000 Oct 20;293(1):13–16. doi: 10.1016/s0304-3940(00)01482-8. [DOI] [PubMed] [Google Scholar]
  22. Kim S., Dougherty E. R., Chen Y., Sivakumar K., Meltzer P., Trent J. M., Bittner M. Multivariate measurement of gene expression relationships. Genomics. 2000 Jul 15;67(2):201–209. doi: 10.1006/geno.2000.6241. [DOI] [PubMed] [Google Scholar]
  23. Kuivaniemi H., Savolainen E. R., Kivirikko K. I. Human placental lysyl oxidase. Purification, partial characterization, and preparation of two specific antisera to the enzyme. J Biol Chem. 1984 Jun 10;259(11):6996–7002. [PubMed] [Google Scholar]
  24. Lee R., Kermani P., Teng K. K., Hempstead B. L. Regulation of cell survival by secreted proneurotrophins. Science. 2001 Nov 30;294(5548):1945–1948. doi: 10.1126/science.1065057. [DOI] [PubMed] [Google Scholar]
  25. Li W., Nellaiappan K., Strassmaier T., Graham L., Thomas K. M., Kagan H. M. Localization and activity of lysyl oxidase within nuclei of fibrogenic cells. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12817–12822. doi: 10.1073/pnas.94.24.12817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lin T. H., Rosales C., Mondal K., Bolen J. B., Haskill S., Juliano R. L. Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase. J Biol Chem. 1995 Jul 7;270(27):16189–16197. doi: 10.1074/jbc.270.27.16189. [DOI] [PubMed] [Google Scholar]
  27. Mao M., Yu M., Tong J. H., Ye J., Zhu J., Huang Q. H., Fu G., Yu L., Zhao S. Y., Waxman S. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5910–5914. doi: 10.1073/pnas.93.12.5910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mounho B. J., Burchiel S. W. Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: possible associations with cytochrome P450 metabolism and increased protein tyrosine phosphorylation. Toxicol Appl Pharmacol. 1998 Mar;149(1):80–89. doi: 10.1006/taap.1997.8345. [DOI] [PubMed] [Google Scholar]
  29. Nam T. J., Busby W. H., Jr, Rees C., Clemmons D. R. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Endocrinology. 2000 Mar;141(3):1100–1106. doi: 10.1210/endo.141.3.7386. [DOI] [PubMed] [Google Scholar]
  30. Nebert D. W. Drug metabolism and signal transduction: possible role of Ah receptor and arachidonic acid cascade in protection from ethanol toxicity. EXS. 1994;71:231–240. doi: 10.1007/978-3-0348-7330-7_23. [DOI] [PubMed] [Google Scholar]
  31. Nichols T. C., du Laney T., Zheng B., Bellinger D. A., Nickols G. A., Engleman W., Clemmons D. R. Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling. Circ Res. 1999 Nov 26;85(11):1040–1045. doi: 10.1161/01.res.85.11.1040. [DOI] [PubMed] [Google Scholar]
  32. Schedlich Lynette J., Graham Lloyd D. Role of insulin-like growth factor binding protein-3 in breast cancer cell growth. Microsc Res Tech. 2002 Oct 1;59(1):12–22. doi: 10.1002/jemt.10173. [DOI] [PubMed] [Google Scholar]
  33. Shu Yujing, Hoshi Sachi, Tomari Shinsuke, Watanabe Teruo, Nagata Michio. Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis. Pathol Int. 2002 Mar;52(3):214–223. doi: 10.1046/j.1440-1827.2002.01339.x. [DOI] [PubMed] [Google Scholar]
  34. Singh S. U., Casper R. F., Fritz P. C., Sukhu B., Ganss B., Girard B., Jr, Savouret J. F., Tenenbaum H. C. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J Endocrinol. 2000 Oct;167(1):183–195. doi: 10.1677/joe.0.1670183. [DOI] [PubMed] [Google Scholar]
  35. Sodek Jaro, Zhu Baoqian, Huynh My-Hang, Brown Theodore J., Ringuette Maurice. Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect Tissue Res. 2002;43(2-3):308–319. doi: 10.1080/03008200290001050. [DOI] [PubMed] [Google Scholar]
  36. Song Y. L., Ford J. W., Gordon D., Shanley C. J. Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):982–988. doi: 10.1161/01.atv.20.4.982. [DOI] [PubMed] [Google Scholar]
  37. Soprano Dianne Robert, Soprano Kenneth J. Pharmacological doses of some synthetic retinoids can modulate both the aryl hydrocarbon receptor and retinoid receptor pathways. J Nutr. 2003 Jan;133(1):277S–281S. doi: 10.1093/jn/133.1.277S. [DOI] [PubMed] [Google Scholar]
  38. Toyoda H., Komurasaki T., Uchida D., Takayama Y., Isobe T., Okuyama T., Hanada K. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem. 1995 Mar 31;270(13):7495–7500. doi: 10.1074/jbc.270.13.7495. [DOI] [PubMed] [Google Scholar]
  39. Vondracek Martin, Weaver David A., Sarang Zsolt, Hedberg Jesper J., Willey James C., Wärngård Lars, Grafström Roland C. Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes. Int J Cancer. 2002 Jun 20;99(6):776–782. doi: 10.1002/ijc.10408. [DOI] [PubMed] [Google Scholar]
  40. Wilson Emily, Parrish Alan R., Bral Christopher M., Williams E. Spencer, Ramos Kenneth S. Collagen suppresses the proliferative phenotype of allylamine-injured vascular smooth muscle cells. Atherosclerosis. 2002 Jun;162(2):289–297. doi: 10.1016/s0021-9150(01)00718-3. [DOI] [PubMed] [Google Scholar]
  41. Xie Y., Sakatsume M., Nishi S., Narita I., Arakawa M., Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 2001 Nov;60(5):1645–1657. doi: 10.1046/j.1523-1755.2001.00032.x. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES